The activity and expression of several PLA2 isoforms are increased in several human cancers, including breast, pancreatic and prostate cancers, suggesting that these enzymes may have a central role in both tumor development and progression and thus can be targets for anticancer drugs [12,57]. The gene discussed is PLA2G2A; the disease is Familial prostate cancer.